摘要
目的:探索HCVDNA核酸免疫效应。方法:将构建的重组体pCDHCVs免疫Balb/c小鼠,用ELISA和3HTdR掺入法检测了免疫鼠血清抗体、脾细胞和PBMC对HCV抗原的增殖反应。结果:重组体pCDHCV1、pCDHCV2和pCDHCV3均可诱导小鼠(n=6)产生抗体(0.665~0.707,OD值)和脾细胞对HCV抗原增殖反应(n=6,SI为3.89~4.47),但各重组体间的免疫效应无显著性差异(P>0.05);免疫鼠(n=12)血清经40倍和320倍稀释后,抗体阳性率分别为100.0%和16.6%;重组体还可诱导鼠PBMC对HCV抗原的增殖反应(3.69~4.07,SI)。结论:pCDHCVs重组体可诱导小鼠产生免疫反应,该结果对进一步开展HCVDNA疫苗研制将具有重要意义。
Objective:To explore the effect of HCV DNA nucleicacid
immunity.Methods:Recombinant pCD HCVs constructs were injected into muscles of Balb/c
mice and serum anti HCV were tested by ELISA(OD value).Spleen cells and PBMC proliferation
responses to HCV antigens were detected by 3 H TdR incorporation
method(cpm).Results:Recombinant pCD HCV 1,pCD HCV 2and pCD HCV 3 can all elicite mice
to generate antibody(0.665~0.707,OD value) and spleen cells in mice ( n =6) were induced to
be proliferative responses to HCV antigens(3.89~4.47),stimulation index(SI).There were no
significant difference( P> 0.05)among each recombinant,the serum antibody in mice( n =12)
immunized by recombinant pCDHCVs were 100.0 percent positive and 16.6 percent positive
when serum were diludted 40 flods and 320 flods respectively.PBMC proliferative responses to
HCV antigens in mice immunized with pCD HCVs was detected also(3.69~
4.07,SI).Conclusion:The investigations suggested that recombinant pCD HCVs can elicite
Balb/c mice to generate immune response and the experiment results have an important
significant for development of HCV DNA vaccine in future.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
1999年第4期155-157,共3页
Chinese Journal of Immunology
基金
国家自然科学基金
关键词
HCV-DNA重组体
核酸免疫
抗体反应
细胞免疫
HCV DNA recombinant\
Nucleicacid immunity\ Antibody responses\ Cellular immunity